Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2025-12-25 @ 10:32 PM
Study NCT ID:
NCT01333358
Status:
UNKNOWN
Last Update Posted:
2011-04-25
First Post:
2011-04-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients
Sponsor:
Central Texas Neurology Consultants
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IND 111746
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Central Texas Neurology Consultants
Old Organization:
Corporation
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |